Literature DB >> 10320718

Distribution of orexin neurons in the adult rat brain.

T Nambu1, T Sakurai, K Mizukami, Y Hosoya, M Yanagisawa, K Goto.   

Abstract

Orexin (ORX)-A and -B are recently identified neuropeptides, which are specifically localized in neurons within and around the lateral hypothalamic area (LHA) and dorsomedial hypothalamic nucleus (DMH), the regions classically implicated in feeding behavior. Here, we report a further study of the distribution of ORX-containing neurons in the adult rat brain to provide a general overview of the ORX neuronal system. Immunohistochemical study using anti-ORX antiserum showed ORX-immunoreactive (ir) neurons specifically localized within the hypothalamus, including the perifornical nucleus, LHA, DMH, and posterior hypothalamic area. ORX-ir axons and their varicose terminals showed a widespread distribution throughout the adult rat brain. ORX-ir nerve terminals were observed throughout the hypothalamus, including the arcuate nucleus and paraventricular hypothalamic nucleus, regions implicated in the regulation of feeding behavior. We also observed strong staining of ORX-ir varicose terminals in areas outside the hypothalamus, including the cerebral cortex, medial groups of the thalamus, circumventricular organs (subfornical organ and area postrema), limbic system (hippocampus, amygdala, and indusium griseum), and brain stem (locus coeruleus and raphe nuclei). These results indicate that the ORX system provides a link between the hypothalamus and other brain regions, and that ORX-containing LHA and DMH neurons play important roles in integrating the complex physiology underlying feeding behavior. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10320718     DOI: 10.1016/s0006-8993(99)01336-0

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  225 in total

Review 1.  Drug treatment of obesity: from past failures to future successes?

Authors:  P Collins; G Williams
Journal:  Br J Clin Pharmacol       Date:  2001-01       Impact factor: 4.335

Review 2.  Chemistry and biology of orexin signaling.

Authors:  Thomas Kodadek; Di Cai
Journal:  Mol Biosyst       Date:  2010-06-07

3.  Release of hypocretin (orexin) during waking and sleep states.

Authors:  Lyudmila I Kiyashchenko; Boris Y Mileykovskiy; Nigel Maidment; Hoa A Lam; Ming-Fung Wu; Joshi John; John Peever; Jerome M Siegel
Journal:  J Neurosci       Date:  2002-07-01       Impact factor: 6.167

4.  Selective enhancement of synaptic inhibition by hypocretin (orexin) in rat vagal motor neurons: implications for autonomic regulation.

Authors:  Scott F Davis; Kevin W Williams; Weiye Xu; Nicholas R Glatzer; Bret N Smith
Journal:  J Neurosci       Date:  2003-05-01       Impact factor: 6.167

5.  [The neurotransmitter, hypocretin. An overview].

Authors:  C Baumann; C Bassetti
Journal:  Nervenarzt       Date:  2004-04       Impact factor: 1.214

Review 6.  Tobacco addiction and the dysregulation of brain stress systems.

Authors:  Adrie W Bruijnzeel
Journal:  Neurosci Biobehav Rev       Date:  2012-03-03       Impact factor: 8.989

7.  Orexin A in rat rostral ventrolateral medulla is pressor, sympatho-excitatory, increases barosensitivity and attenuates the somato-sympathetic reflex.

Authors:  Israt Z Shahid; Ahmed A Rahman; Paul M Pilowsky
Journal:  Br J Pharmacol       Date:  2012-04       Impact factor: 8.739

Review 8.  It's complicated: The relationship between sleep and Alzheimer's disease in humans.

Authors:  Brendan P Lucey
Journal:  Neurobiol Dis       Date:  2020-07-29       Impact factor: 5.996

9.  Orexin inputs to caudal raphé neurons involved in thermal, cardiovascular, and gastrointestinal regulation.

Authors:  Hans-Rudolf Berthoud; Laurel M Patterson; Gregory M Sutton; Christopher Morrison; Huiyuan Zheng
Journal:  Histochem Cell Biol       Date:  2005-03-02       Impact factor: 4.304

10.  Attenuated orexinergic signaling underlies depression-like responses induced by daytime light deficiency.

Authors:  S P Deats; W Adidharma; J S Lonstein; L Yan
Journal:  Neuroscience       Date:  2014-05-09       Impact factor: 3.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.